Kevin W Ng

Employment

• Rockefeller University Postdoctoral Fellow
  2022 - Present
• The Francis Crick Institute PhD Candidate
  2017 - 2022
• University College London Undergraduate research assistant
  2016 - 2016
• BC Cancer Research Centre Undergraduate research assistant
  2015 - 2017
• University of British Columbia Undergraduate research assistant
  2015 - 2016

Education

• The Francis Crick Institute London PhD
  2017 - 2022

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin
  Journal of Clinical Investigation 2023 DOI: 10.1172/JCI164397
  +Save
• Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
  Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield +97 more
  Nature 2023 DOI: 10.1038/s41586-023-05771-9
  +Save
• B cell responses to the gut microbiota.
  Advances in immunology 2022 DOI: 10.1016/bs.ai.2022.08.003
  +Save
• An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
  Cancer Research 2022 DOI: 10.1158/0008-5472.CAN-22-0325
  +Save
• RETRACTED: SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
  Science Translational Medicine 2022 DOI: 10.1126/scitranslmed.abn3715
  +Save
• GREM1 is required to maintain cellular heterogeneity in pancreatic cancer.
  Linxiang Lan, Theodore Evan, Huafu Li

  +18 more

  • Aasia Hussain
  • E. Josue Ruiz
  • May Zaw Thin
  • Rute M. M. Ferreira
  • Hari PS
  • +13 more
  Nature 2022 DOI: 10.1038/s41586-022-04888-7
  +Save
• The molecular and cellular mechanisms associated with the destruction of terminal bronchioles in COPD.
  The European respiratory journal 2022 DOI: 10.1183/13993003.01411-2021
  +Save
• Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
  Nature cancer 2021 DOI: 10.1038/s43018-021-00275-9
  +Save
• Favourable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
  Claire T. Deakin, Georgina H. Cornish, Kevin W. Ng +28 more
  Med 2021 DOI: 10.1016/j.medj.2021.08.001
  +Save
• Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
  eLife 2021 DOI: 10.7554/eLife.69317
  +Save
• Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
  Seminars in Immunology 2021 DOI: 10.1016/j.smim.2021.101507
  +Save
• SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
  Science Advances 2021 DOI: 10.1126/sciadv.abg7607
  +Save
• The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF).
  EBioMedicine 2021 DOI: 10.1016/j.ebiom.2021.103325
  +Save
• Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
  Science 2020 DOI: 10.1126/science.abe1107
  +Save
• Assessment of long non-coding RNA expression reveals novel mediators of the lung tumour immune response
  Scientific Reports 2020 DOI: 10.1038/s41598-020-73787-6
  +Save
• Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option
  Nature Genetics 2020 DOI: 10.1038/s41588-020-00732-8
  +Save
• Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.
  Nature communications 2019 DOI: 10.1038/s41467-019-13295-y
  +Save
• Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist.
  eLife 2019 DOI: 10.7554/elife.50256
  +Save
• Discovery of Previously Undetected MicroRNAs in Mesothelioma and Their Use as Tissue-of-Origin Markers.
  American journal of respiratory cell and molecular biology 2019 DOI: 10.1165/rcmb.2018-0204le
  +Save
• Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma.
  Oncoimmunology 2018 DOI: 10.1080/2162402X.2018.1504728
  +Save